MARKSANS PHARMA
|
MARKSANS PHARMA Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹2,747 Cr | ₹2,290 Cr | ₹2,040 Cr | ₹1,549 Cr | ₹1,392 Cr |
| Sales | ₹2,738 Cr | ₹2,286 Cr | ₹2,037 Cr | ₹1,538 Cr | ₹1,384 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹8.40 Cr | ₹3.21 Cr | ₹2.52 Cr | ₹11 Cr | ₹7.81 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹2,623 Cr | ₹2,177 Cr | ₹1,852 Cr | ₹1,491 Cr | ₹1,376 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-184 Cr | ₹-74 Cr | ₹-6.39 Cr | ₹13 Cr | ₹-136 Cr |
| Raw Material Consumed | ₹1,328 Cr | ₹1,112 Cr | ₹928 Cr | ₹704 Cr | ₹731 Cr |
| Opening Raw Materials | ₹262 Cr | ₹203 Cr | ₹151 Cr | ₹118 Cr | ₹92 Cr |
| Purchases Raw Materials | ₹797 Cr | ₹727 Cr | ₹665 Cr | ₹574 Cr | ₹446 Cr |
| Closing Raw Materials | ₹306 Cr | ₹262 Cr | ₹203 Cr | ₹151 Cr | ₹118 Cr |
| Other Direct Purchases / Brought in cost | ₹574 Cr | ₹444 Cr | ₹315 Cr | ₹163 Cr | ₹312 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹40 Cr | ₹37 Cr | ₹24 Cr | ₹19 Cr | ₹16 Cr |
| Electricity & Power | ₹40 Cr | ₹37 Cr | ₹24 Cr | ₹19 Cr | ₹16 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | ₹0.47 Cr |
| Employee Cost | ₹350 Cr | ₹294 Cr | ₹239 Cr | ₹220 Cr | ₹197 Cr |
| Salaries, Wages & Bonus | ₹326 Cr | ₹275 Cr | ₹223 Cr | ₹204 Cr | ₹180 Cr |
| Contributions to EPF & Pension Funds | ₹21 Cr | ₹17 Cr | ₹13 Cr | ₹16 Cr | ₹16 Cr |
| Workmen and Staff Welfare Expenses | ₹1.54 Cr | ₹1.35 Cr | ₹0.77 Cr | ₹0.68 Cr | ₹2.09 Cr |
| Other Employees Cost | ₹1.92 Cr | ₹0.10 Cr | ₹1.78 Cr | ₹0.40 Cr | - |
| Other Manufacturing Expenses | ₹140 Cr | ₹95 Cr | ₹96 Cr | ₹13 Cr | ₹50 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹86 Cr | ₹59 Cr | - | - | - |
| Repairs and Maintenance | ₹54 Cr | ₹36 Cr | ₹19 Cr | ₹13 Cr | ₹10 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | - | - | ₹78 Cr | - | ₹39 Cr |
| General and Administration Expenses | ₹118 Cr | ₹94 Cr | ₹53 Cr | ₹38 Cr | ₹51 Cr |
| Rent , Rates & Taxes | ₹15 Cr | ₹16 Cr | ₹15 Cr | ₹7.18 Cr | ₹15 Cr |
| Insurance | - | - | - | - | ₹12 Cr |
| Printing and stationery | ₹2.26 Cr | ₹1.74 Cr | ₹1.34 Cr | ₹0.91 Cr | ₹1.15 Cr |
| Professional and legal fees | ₹85 Cr | ₹62 Cr | ₹14 Cr | ₹21 Cr | ₹17 Cr |
| Traveling and conveyance | ₹12 Cr | ₹11 Cr | ₹9.05 Cr | ₹6.12 Cr | ₹2.93 Cr |
| Other Administration | ₹3.71 Cr | ₹3.25 Cr | ₹13 Cr | ₹2.41 Cr | ₹2.72 Cr |
| Selling and Distribution Expenses | ₹257 Cr | ₹127 Cr | ₹133 Cr | ₹119 Cr | ₹111 Cr |
| Advertisement & Sales Promotion | - | - | - | - | - |
| Sales Commissions & Incentives | - | - | - | - | - |
| Freight and Forwarding | ₹144 Cr | ₹92 Cr | ₹103 Cr | ₹119 Cr | ₹79 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹113 Cr | ₹36 Cr | ₹31 Cr | - | ₹32 Cr |
| Miscellaneous Expenses | ₹46 Cr | ₹34 Cr | ₹45 Cr | ₹107 Cr | ₹16 Cr |
| Bad debts /advances written off | ₹6.39 Cr | ₹3.19 Cr | ₹14 Cr | ₹2.63 Cr | ₹14 Cr |
| Provision for doubtful debts | ₹1.94 Cr | ₹1.97 Cr | - | - | - |
| Losson disposal of fixed assets(net) | ₹0.03 Cr | - | ₹0.26 Cr | - | ₹0.01 Cr |
| Losson foreign exchange fluctuations | - | - | - | - | ₹0.97 Cr |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹37 Cr | ₹29 Cr | ₹31 Cr | ₹104 Cr | ₹0.84 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹2,094 Cr | ₹1,719 Cr | ₹1,513 Cr | ₹1,232 Cr | ₹1,037 Cr |
| Operating Profit (Excl OI) | ₹529 Cr | ₹459 Cr | ₹339 Cr | ₹259 Cr | ₹340 Cr |
| Other Income | ₹70 Cr | ₹50 Cr | ₹59 Cr | ₹42 Cr | ₹6.69 Cr |
| Interest Received | ₹30 Cr | ₹34 Cr | ₹12 Cr | ₹5.97 Cr | ₹1.16 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | ₹0.09 Cr | - | - | ₹0.04 Cr |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | ₹23 Cr | ₹8.24 Cr | ₹40 Cr | ₹21 Cr | - |
| Others | ₹17 Cr | ₹8.30 Cr | ₹7.50 Cr | ₹15 Cr | ₹5.50 Cr |
| Operating Profit | ₹599 Cr | ₹509 Cr | ₹399 Cr | ₹301 Cr | ₹346 Cr |
| Interest | ₹12 Cr | ₹11 Cr | ₹9.13 Cr | ₹8.45 Cr | ₹7.99 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | - | - | ₹3.03 Cr | ₹2.71 Cr | ₹4.17 Cr |
| Other Interest | ₹12 Cr | ₹11 Cr | ₹6.10 Cr | ₹5.74 Cr | ₹3.82 Cr |
| PBDT | ₹587 Cr | ₹498 Cr | ₹390 Cr | ₹292 Cr | ₹338 Cr |
| Depreciation | ₹83 Cr | ₹74 Cr | ₹52 Cr | ₹45 Cr | ₹36 Cr |
| Profit Before Taxation & Exceptional Items | ₹504 Cr | ₹424 Cr | ₹338 Cr | ₹248 Cr | ₹302 Cr |
| Exceptional Income / Expenses | - | - | - | - | - |
| Profit Before Tax | ₹504 Cr | ₹424 Cr | ₹338 Cr | ₹248 Cr | ₹302 Cr |
| Provision for Tax | ₹121 Cr | ₹109 Cr | ₹72 Cr | ₹61 Cr | ₹64 Cr |
| Current Income Tax | ₹127 Cr | ₹113 Cr | ₹72 Cr | ₹57 Cr | ₹67 Cr |
| Deferred Tax | ₹-7.24 Cr | ₹-5.11 Cr | ₹1.10 Cr | ₹3.59 Cr | ₹-3.07 Cr |
| Other taxes | ₹1.31 Cr | ₹0.43 Cr | ₹-0.33 Cr | ₹0.01 Cr | - |
| Profit After Tax | ₹383 Cr | ₹315 Cr | ₹265 Cr | ₹187 Cr | ₹239 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | ₹-2.04 Cr | ₹-1.20 Cr | ₹0.99 Cr | ₹-2.25 Cr | ₹-2.60 Cr |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹381 Cr | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹1,069 Cr | ₹778 Cr | ₹509 Cr | ₹335 Cr | ₹85 Cr |
| Appropriations | ₹1,450 Cr | ₹1,091 Cr | ₹776 Cr | ₹519 Cr | ₹321 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹27 Cr | ₹22 Cr | ₹-6.99 Cr | ₹10 Cr | ₹-14 Cr |
| Equity Dividend % | ₹80.00 | ₹60.00 | ₹50.00 | ₹25.00 | ₹25.00 |
| Earnings Per Share | ₹8.40 | ₹6.92 | ₹5.88 | ₹4.51 | ₹5.76 |
| Adjusted EPS | ₹8.40 | ₹6.92 | ₹5.88 | ₹4.51 | ₹5.76 |
Compare Income Statement of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,017.1 Cr | -0% | 3.2% | -35.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -0% |
3.2% |
-35.1% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses